The Next Generation of Mouse Model Preparation Platform
- 4-Week Delivery: World’s fastest custom mouse model development.
- TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
- Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
- Validated Quality: Guaranteed high precision and model viability.
About VeloGene Biotechnology
維洛基因生物科技
A wholly-owned subsidiary of Guangzhou MingCeler Biotech
TurboMice™ - From Cell to Mice in 45 Days
VeloGene Biotechnology(維洛基因生物科技）
From MingCeler to VeloGene: Accelerating the Future of Biomedical Research
Throughout our journey, MingCeler has established a strong foundation in China, consistently delivering innovative solutions to the domestic scientific and industrial communities. However, our vision extends far beyond our roots. We are committed to empowering researchers and industrial partners across the globe, ensuring that our groundbreaking technology is accessible to those driving the future of medicine.In 2026, we officially launched our international brand, VeloGene Biotechnology."Velo" is derived from Velocity, symbolizing our unwavering dedication to speed and efficiency. We recognize that in the rapidly evolving landscape of biomedical R&D, time is the ultimate competitive advantage. Through our advanced TurboMice™ technology platform, VeloGene empowers you to accelerate your development pipeline and stay one step ahead in your research.From MingCeler to VeloGene, this rebranding marks a strategic milestone in our global expansion. It reflects our commitment to serving as a premier global accelerator for biomedical innovation, bridging the gap from laboratory discovery to clinical application with unparalleled precision and speed.
As part of this global transition, our primary English operations have officially migrated from mingceler.com to velogene.com, alongside the launch of our dedicated regional platform at velogene.kr to better serve our customers in South Korea.
A Company that Accelerates Your Research By 45 Days From Cell to Mice - Global Leaders in Mouse Model Customize Services
Advancing Animal Welfare: Fully Compliant with the 4R Principles
Comprehensive Gene-Edited Mouse Model Capabilities & Fast Delivery
- Knockout (KO) & Conditional Knockout (CKO) mouse models
- Knock-In (KI) & Large-Fragment Knock-In (LFKI) integrations
- Point Mutation (PM) and full human genomic replacement (Humanization)
Bypassing Chimera Breeding: The Tetraploid Complementation Advantage
What truly sets VeloGene apart in the mouse model customize market is our exclusive tetraploid complementation technology. This revolutionary advancement redefines the entire workflow of transgenic and gene-edited mouse production. Our core platform completely bypasses the cumbersome, time-consuming processes of chimera breeding and heterozygous crossbreeding.Edited ESCs are developed directly into viable, genetically stable F0 mice that are immediately ready for experimental use. By eliminating traditional breeding generations, we remove all associated variables, genotypes uncertainties, and colony management delays. This not only streamlines the generation process but also guarantees unrivaled product quality and consistency, allowing researchers to initiate their in vivo experiments promptly without waiting for multiple generational cycles.
VeloGene Core Team
Dr. Wu Guangming
Founder & Chief Scientist, MingCeler Biotech | Professor, Guangzhou Laboratory
Dr. Guangming Wu is Founder and Chief Scientist at MingCeler Biotech and VeloGene Biotech, and Professor at Guangzhou Laboratory. He previously served as Research Associate and Postdoctoral Fellow at internationally renowned institutions including the New England Animal Medical Center, Brown University, the University of Missouri-Columbia and Temple University School of Medicine. In 2004, he joined the Max Planck Institute for Molecular Biomedicine (MPI) in Germany, where he collaborated with Prof. Hans R. Schöler (Member of the German National Academy of Sciences) on the mechanisms of mouse embryo development and stem cell biology.
Dr. Zhao
Production Director
- Previously served as Platform Leader and Deputy Director at Shanghai Model Organisms Center and GemPharmatech, recognized as a senior gene editing expert with 15 years of hands-on research and practical experience in gene editing.
- Led the team in establishing efficient gene editing platforms for mice, cells, and bacteria.
- Led the world’s largest mouse model development project — the Spotted Mouse Project.
Garland
Sales Director
- Graduated at University of Toronto
- 10+ years of combined laboratory and international sales experience, specializing in AAV, cell, and rodent (mouse/rat) model,CRO solutions.
- Successfully managed over hundreds of projects as a Custom Model Consultant Previourly at Cyagen across APEC and EU regions, driving client success in life science research.
VeloGene Contact Info
Location:
Units 04-05, 16/F, 54-62 Lockhart Road, Wan Chai, Hong Kong
Telephone:
+86 (400)838-8113
Email:
info@velogene.com
Outbound Resource About VeloGene
IP Assurance
At VeloGene, we operate on a strict fee-for-service model. All intellectual property (IP) and materials created for your project are 100% yours. We take every measure to safeguard your IP, ensuring no vectors, ES cells, or mouse lines are retained or resold to third parties. This way, you can focus on your research with complete peace of mind.